Besides, it is also interesting to explore the relationship between S100A4 and other chemotherapeutic agents such as gemcitabine, flexibiotics, and vincristine, which may broaden the clinical applications of S100A4 knockdown, such as the treatment of other cancers and cytarabine high-dose therapy. The gene discussed is S100A4; the disease is cancer.